Sort
64,565 grants matching “drug discovery”
Open Drug Discovery Center for Alzheimer's Disease
$1,971,420Allan I Levey · Emory University · U54 · FY2022 · AG
Leveraging Natural Phenotypic Variations of Heterogenous ALS Populations-in-a-Dish to Enable Scalable Drug Discovery
$1,968,019Justin Kawika Ichida · University Of Southern California · R01 · FY2025 · NS
Transdisciplinary Team Science in Colorectal Cancer Prognosis: the ColoCare Study
$1,967,702Cornelia M Ulrich · University Of Utah · U01 · FY2020 · CA
Discovery Pipeline (2 of 4)
$1,967,213Todd R. Golub · Massachusetts Institute Of Technology · RL1 · FY2007 · CA
DEVELOPMENTAL BIOLOGY OF HUMAN ERYTHROPOIESIS
$1,966,807Stuart H Orkin · Boston Children'S Hospital · P01 · FY2014 · HL
Resource for the Development of Biomedical Accelerator Mass Spectrometry (AMS)
$1,966,400Kenneth W Turteltaub · University Of Calif-Lawrnc Lvrmr Nat Lab · P41 · FY2014 · GM
An upgrade of the area detector for the FMX beamline at NSLS-II
$1,964,800Qun Liu · State University New York Stony Brook · S10 · FY2025 · OD
Roles Of Brain Neuroimmune System In Neurodegeneration
$1,963,531Jau-Shyong Shyong Hong · Environmental Health Sciences · Z01 · FY2007 · ES
Children's Oncology Group
$1,962,900Todd A Alonzo · University Of Southern California · U10 · FY2025 · CA
Pharmacological Treatment of Retinal Diseases
$1,962,726Krzysztof Palczewski · Case Western Reserve University · R24 · FY2013 · EY
Pharmacological Treatment of Retinal Diseases
$1,962,726Krzysztof Palczewski · Case Western Reserve University · R24 · FY2012 · EY
Pharmacological Treatment of Retinal Diseases
$1,962,726Krzysztof Palczewski · Case Western Reserve University · R24 · FY2014 · EY
Pharmacological Treatment of Retinal Diseases
$1,962,726Krzysztof Palczewski · Case Western Reserve University · R24 · FY2011 · EY
Preclinical drug development in pancreatic cancer
$1,962,634Udo Rudloff · Division Of Basic Sciences - Nci · ZIA · FY2021 · CA
Vascular remodeling in patients with rare genetic disorders
$1,961,950Manfred Boehm · National Heart, Lung, And Blood Institute · ZIA · FY2022 · HL
Establishing Biomarkers and Clinical Endpoints in Myotonic Dystrophy Type-1
$1,961,707Nicholas Elwood Johnson · Virginia Commonwealth University · R01 · FY2017 · FD
Analytical Chemistry
$1,960,710Paul Shinn · National Center For Advancing Translational Sciences · ZIC · FY2018 · TR
Project 2
$1,960,505Charles G. Mullighan · St. Jude Children'S Research Hospital · U54 · FY2019 · CA
Open Drug Discovery Center for Alzheimer's Disease
$1,960,446Allan I Levey · Emory University · U54 · FY2019 · AG
Program for Resistance, Immunology, Surveillance & Modeling of Malaria in Uganda (PRISM) Renewal
$1,959,793Matthew G Dorsey · University Of California, San Francisco · U19 · FY2021 · AI
Open Drug Discovery Center for Alzheimer's Disease
$1,959,446Allan I Levey · Emory University · U54 · FY2021 · AG
Open Drug Discovery Center for Alzheimer's Disease
$1,958,980Allan I Levey · Emory University · U54 · FY2023 · AG
DATA SCIENCE RESEARCH
$1,958,853Peipei Ping · University Of California Los Angeles · U54 · FY2015 · GM
A Novel Monkey Model for Parkinson's Drug Discovery
$1,958,552Howard J. Federoff · Georgetown University · RC2 · FY2009 · NS
Orchestrating Tendon Regeneration through Nanoparticle Drug Delivery
$1,958,125Danielle S. Benoit · University Of Oregon · R01 · FY2025 · AR